VJHemOnc is committed to improving our service to you

EBMT 2020 | NK-CAR immunotherapy: the next steps

VJHemOnc is committed to improving our service to you

Evelyn Ullrich

Evelyn Ullrich, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, discusses the next steps with respect to NK-CAR immunotherapy, highlighting a multicenter Phase II study and issues for future studies. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter